CommercialCoverageMedium impact
Reyvow (lasmiditan)
Blue Cross & Blue Shield of Mississippi·MS · Neurology, Family Medicine, Internal Medicine +1 more·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi has updated their policy on Reyvow (lasmiditan) for migraine treatment, maintaining that it is considered not medically necessary due to availability of other covered alternatives. The policy reinforces that State Health Plan members should check formulary coverage through their pharmacy benefit manager.
Action Required
Immediately: Billing team should verify formulary coverage for Reyvow (lasmiditan) prescriptions by performing drug searches on patient member IDs before prescribing. For State Health Plan members, check coverage at https://www.dfa.ms.gov/cvs-caremark and submit prior authorization requests to the pharmacy benefit manager. Document medical necessity if prescribing, as BCBS MS may request medical records for coverage determination.